United Therapeutics has been an avid supporter of the Pulmonary Hypertension Association
(PHA). The PHA works to raise awareness of PAH at both a national level, with activities
such as the Physician/Allied Healthcare Professional Medical Education Seminars
and International Patient Conferences, and at a local level through patient support
groups or via fundraisers such as walk-a-thons or golf tournaments. We support all
of these activities both financially and through the participation of our partners
and employees. We were the first company to sponsor a $1 million endowment for the
PHA and we are a charter member of the PHA's Corporate Committee, which is made
up of other members of the pharmaceutical industry serving the PAH community. The
Corporate Committee offers guidance to the PHA on various issues related to market
dynamics as they affect patients with PAH, and drug access issues, among many other
topics. In 2008, United Therapeutics received the prestigious PHA "Friends of the
Family Award" in recognition of its continued support of the PHA and the patients
United Therapeutics has an active grants program to fund grants for research, scientific
education or patient and charitable organizations. To inquire about our grants program
or apply for a grant, please e-mail us at email@example.com.
United Therapeutics evaluates all grants in accordance with the criteria set forth
Comprehensive Compliance Program. Submission of a grant request does not
guarantee funding by United Therapeutics. If you are awarded funding, any amount
paid or reimbursed related to your grant is not intended to be, nor shall it be
construed as, an offer or payment made, whether directly or indirectly, to induce
the referral of patients, the purchase or order of United Therapeutics' pharmaceutical
products, the recommending or arranging for the purchase or order of United Therapeutics'
pharmaceutical products, or an obligation, either express or implied, to prescribe
or otherwise support United Therapeutics' pharmaceutical products.
United Therapeutics Corporation proudly sponsors the Hamilton Naki-MESAB-United
Therapeutics Scholarship at the University of Cape Town (UCT). The scholarship was
created in 2007 in order to provide a medical student with a full scholarship to
attend medical school at UCT. United Therapeutics has pledged to fund an all-expense
paid scholarship of $12,000 annually for six years. We came to partner with UCT
through the inspired work of Dr. Louis Sullivan, a member of our Board of Directors.
The Hamilton Naki-MESAB-United Therapeutics Scholarship is named in honor of Hamilton
Naki. Naki has become a famous symbol of heart transplantation in South Africa.
History places him as a close collaborator with Dr. Christian Barnard when he performed
the first heart transplant at Groote Schuur Hospital in South Africa in 1967. Naki
is recognized in many circles to have directly assisted Dr. Barnard as an integral
part of the surgical team. In later years, he was widely honored and decorated for
his roles as teacher, trainer and surgical assistant, even though he was overlooked
during the apartheid years in South Africa. Naki was the recipient of the Order
of Mapungubwe, South Africa's highest honor, in 2002 and was awarded an honorary
Master of Science in Medicine by UCT in 2003. Naki died in 2005.